Study of CDx's device for detection of biliary-tract cancer is completed

10/13/2013 |

CDx Diagnostics said it has wrapped up a clinical trial evaluating the use of its Wide Area Transepithelial Sample, or WATS, system in diagnosing biliary-tract cancer. The device works by collecting a wide area tissue sample and subjecting it to a computer-aided 3D examination to identify problematic cells.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ